# Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer

> **NCT01724801** · PHASE3 · COMPLETED · sponsor: **Guangdong Association of Clinical Trials** · enrollment: 176 (actual)

## Conditions studied

- Brain Metastasis
- Non Small Cell Lung Cancer

## Interventions

- **RADIATION:** whole brain radiation(WBI)
- **DRUG:** Icotinib

## Key facts

- **NCT ID:** NCT01724801
- **Lead sponsor:** Guangdong Association of Clinical Trials
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10-14
- **Primary completion:** 2015-06-30
- **Final completion:** 2016-09-14
- **Target enrollment:** 176 (ACTUAL)
- **Last updated:** 2017-03-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01724801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01724801, "Icotinib or Whole Brain Irradiation in EGFR-mutant Lung Cancer". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01724801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*